z-logo
open-access-imgOpen Access
Uric Acid-to-Albumin Ratio: A Novel Marker for the Extent of Coronary Artery Disease in Patients with Non-ST-Elevated Myocardial Infarction
Author(s) -
Ender Özgün Çakmak,
Emrah Bayam,
Mehmet Çelık,
Muzaffer Kahyaoğlu,
Kıvanç Eren,
Elmin Imanov,
Ali Karagöz,
İbrahim Akın İzgi
Publication year - 2020
Publication title -
pulse
Language(s) - English
Resource type - Journals
eISSN - 2235-8676
pISSN - 2235-8668
DOI - 10.1159/000514533
Subject(s) - medicine , gastroenterology , myocardial infarction , albumin , uric acid , coronary artery disease , cardiology , percutaneous coronary intervention , endocrinology
Objective: This research aimed to investigate the predictive value of the uric acid-to-serum albumin ratio (UAR) in establishing the severity and extent of coronary artery disease (CAD) with non-ST segment elevation myocardial infarction (NSTEMI) patients. Methods: A total of 402 patients (mean age 63.5 ± 11.6 years) were included in this retrospectively designed study. We compared Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Scores (SS) between low (≤22) and intermediate-high (>22) groups. The UAR, the neutrophil-to-lymphocyte ratio (NLR), and the C-reactive protein-to-albumin ratio (CAR) were evaluated and compared. Results: SS >22 were observed in 30.8% ( n = 124) of the patients, and their UAR, NLR, and CAR were significantly higher. Three separate multivariate analysis models performed as the outcome of a reliable correlation between UAR, NLR, CAR, and consequently UAR (OR = 2.08; 95% CI 1.21–3.58; p = 0.008) and CAR (OR = 3.33; 95% CI 1.85–5.9; p < 0.001) reached significance but NLR (OR = 1.26; 95% CI 0.86–1.84; p = 0.20) clinically trended significance (not statistically). Model performance comparisons demonstrated that UAR is a better predictor regarding likelihood ratios (UAR, 60.95; NLR, 57.8; and CAR, 59.0). Conclusion: As a novel inflammatory marker, UAR independently predicted better outcomes than CAR and might be used reliably in prediction of the extent of CAD in NSTEMI patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here